Treatment with deferasirox (Exjade®) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study
暂无分享,去创建一个
E. Terpos | E. Voskaridou | D. Christoulas | E. Plata | Maroussa Douskou | M. Papadakis | Eleni-Evangelia Delaki